Found: 7
Select item for more details and to access through your institution.
Hidden myelodysplastic syndrome (MDS): A prospective study to confirm or exclude MDS in patients with anemia of uncertain etiology.
- Published in:
- International Journal of Laboratory Hematology, 2019, v. 41, n. 1, p. 109, doi. 10.1111/ijlh.12933
- By:
- Publication type:
- Article
Addition of chemotherapy to nivolumab after PD-1 inhibitor failure as bridge to allogeneic stem cell transplantation in classical Hodgkin's lymphoma: report on three cases and literature review.
- Published in:
- Therapeutic Advances in Hematology, 2021, v. 12, p. 1, doi. 10.1177/20406207211038181
- By:
- Publication type:
- Article
Comparison of transfusion requirements in adult patients undergoing Haploidentical or single‐unit umbilical cord blood stem cell transplantation.
- Published in:
- European Journal of Haematology, 2019, v. 103, n. 3, p. 172, doi. 10.1111/ejh.13270
- By:
- Publication type:
- Article
P-165: Chronological age as a prognostic factor in transplant-ineligible patients with newly diagnosed Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S126, doi. 10.1016/S2152-2650(21)02292-8
- By:
- Publication type:
- Article
Allogeneic hematopoietic stem cell transplantation in patients with multiple myeloma. Impact of disease characteristics, disease status at transplant, and prior number of lines of therapy. Results of retrospective, multicentre Spanish study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e289, doi. 10.1016/j.clml.2019.09.476
- By:
- Publication type:
- Article
Clinical Characteristics and Transfusion Management of Patients Diagnosed of Multiple Myeloma Receiving Daratumumab: Experience of a Single Centre.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e152, doi. 10.1016/j.clml.2019.09.254
- By:
- Publication type:
- Article
Observational study to describe the impact of treatment combinations with Daratumumab versus other alternative regimens in patients with relapsed / refractory multiple myeloma. Spain real world evidence (RWE) data. GeminiS study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e147, doi. 10.1016/j.clml.2019.09.245
- By:
- Publication type:
- Article